## Gene Summary
SYNE2, or spectrin repeat-containing nuclear envelope protein 2, is involved in the anchorage of the nucleus and other organelles in cells. It plays a critical role in maintaining the structural integrity of the nuclear envelope and connecting it to the cytoskeleton, thus aiding in mechanotransduction processes where physical forces are converted to biochemical signals. The protein encoded by SYNE2 is found in a wide range of tissues, exhibiting particularly high expression in skeletal and cardiac muscles, where mechanical stress is frequent.

## Gene Drugs, Diseases, Phenotypes, and Pathways
SYNE2 has been implicated in various diseases, primarily those related to neuromuscular and cardiovascular systems. Mutations in this gene have been associated with diseases such as Emery-Dreifuss muscular dystrophy and dilated cardiomyopathy, conditions known for muscular and cardiac dysfunction. The gene's role in structural and signaling pathways underpins its involvement in these phenotypes. Additionally, SYNE2 has been linked to arrhythmogenic right ventricular dysplasia, a heritable heart disease that can cause heart failure and arrhythmias.

## Pharmacogenetics
The pharmacogenetic implications of SYNE2 are not thoroughly explored, and currently, there are no direct associations of this gene with specific drugs in a pharmacogenetic context. However, given its association with crucial cardiovascular and muscular diseases, research in its pharmacogenetic properties could potentially impact therapeutic strategies for these conditions. Future studies might focus on how variants in SYNE2 could affect responses to drugs used in treating muscular dystrophies and cardiomyopathies, possibly influencing drug efficacy and safety profiles.